Molecular Partners AG (MOLN)

Molecular Partners AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	67.31	87.95	71.81	133.72	75.71
Short-Term Investments	119.58	161.2	61	40	19.37
Cash & Cash Equivalents	186.89	249.14	132.81	173.72	95.08
Cash Growth	-24.99%	87.59%	-23.55%	82.71%	-
Receivables	1.95	1.02	25.65	2.84	2.34
Other Current Assets	3.62	4.59	5.73	1.25	2.5
Total Current Assets	192.46	254.75	164.19	177.81	99.92
Property, Plant & Equipment	5.68	7.24	8.15	9.39	4.24
Goodwill and Intangibles	0.21	0.27	0.33	0.35	0.77
Total Long-Term Assets	5.89	7.51	8.48	9.73	5.01
Total Assets	198.35	262.26	172.67	187.55	104.94
Accounts Payable	1.33	2.14	7.39	5.83	2.41
Current Debt	1.21	1.2	1.19	1.18	1.27
Other Current Liabilities	11.88	13.91	38.29	50.67	24.93
Total Current Liabilities	14.42	17.25	46.87	57.67	28.61
Long-Term Debt	2.44	3.65	4.85	6.04	1.28
Other Long-Term Liabilities	5.06	6.19	13.66	16.62	20.91
Total Long-Term Liabilities	7.51	9.84	18.51	22.66	22.19
Total Liabilities	21.92	27.09	65.38	80.33	50.8
Total Debt	3.65	4.85	6.04	7.22	2.55
Debt Growth	-24.70%	-19.69%	-16.33%	183.61%	-
Retained Earnings	-191.76	-127.78	-250.95	-195.17	-130.87
Shareholders' Equity	176.43	235.17	107.29	107.22	54.14
Net Cash / Debt	183.24	244.29	126.77	166.5	92.54
Net Cash / Debt Growth	-24.99%	92.70%	-23.86%	79.94%	-
Working Capital	178.04	237.5	117.33	120.14	71.32
Book Value Per Share	5.37	7.23	3.34	3.33	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).